244 related articles for article (PubMed ID: 7520098)
1. Identification of an H-2 Kb-presented Moloney murine leukemia virus cytotoxic T-lymphocyte epitope that displays enhanced recognition in H-2 Db mutant bm13 mice.
Sijts AJ; De Bruijn ML; Ressing ME; Nieland JD; Mengedé EA; Boog CJ; Ossendorp F; Kast WM; Melief CJ
J Virol; 1994 Sep; 68(9):6038-46. PubMed ID: 7520098
[TBL] [Abstract][Full Text] [Related]
2. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db mutant) mice. I. Full recognition of Kbm11 by Kb-restricted CTL.
Stukart MJ; Boes J; Melief CJ
J Immunol; 1984 Jul; 133(1):24-7. PubMed ID: 6202782
[TBL] [Abstract][Full Text] [Related]
3. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db-mutant) mice. II. Relationship of Kbm3 and Kbm11 in restriction specificities and allodeterminants.
Stukart MJ; Boes J; Melief CJ
J Immunol; 1984 Jul; 133(1):28-32. PubMed ID: 6202783
[TBL] [Abstract][Full Text] [Related]
4. Immunodominant mink cell focus-inducing murine leukemia virus (MuLV)-encoded CTL epitope, identified by its MHC class I-binding motif, explains MuLV-type specificity of MCF-directed cytotoxic T lymphocytes.
Sijts AJ; Ossendorp F; Mengedé EA; van den Elsen PJ; Melief CJ
J Immunol; 1994 Jan; 152(1):106-16. PubMed ID: 8254184
[TBL] [Abstract][Full Text] [Related]
5. Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors.
Chen W; Qin H; Chesebro B; Cheever MA
J Virol; 1996 Nov; 70(11):7773-82. PubMed ID: 8892898
[TBL] [Abstract][Full Text] [Related]
6. An immunodominant Kb-restricted peptide from the p15E transmembrane protein of endogenous ecotropic murine leukemia virus (MuLV) AKR623 that restores susceptibility of a tumor line to anti-AKR/Gross MuLV cytotoxic T lymphocytes.
White HD; Roeder DA; Green WR
J Virol; 1994 Feb; 68(2):897-904. PubMed ID: 8289392
[TBL] [Abstract][Full Text] [Related]
7. Dissecting the immune response to moloney murine sarcoma/leukemia virus-induced tumors by means of a DNA vaccination approach.
Milan G; Zambon A; Cavinato M; Zanovello P; Rosato A; Collavo D
J Virol; 1999 Mar; 73(3):2280-7. PubMed ID: 9971811
[TBL] [Abstract][Full Text] [Related]
8. Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site.
Beekman NJ; van Veelen PA; van Hall T; Neisig A; Sijts A; Camps M; Kloetzel PM; Neefjes JJ; Melief CJ; Ossendorp F
J Immunol; 2000 Feb; 164(4):1898-905. PubMed ID: 10657639
[TBL] [Abstract][Full Text] [Related]
9. Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells.
Kast WM; Boog CJ; Roep BO; Voordouw AC; Melief CJ
J Immunol; 1988 May; 140(9):3186-93. PubMed ID: 2834454
[TBL] [Abstract][Full Text] [Related]
10. Major and minor Kb-restricted epitopes encoded by the endogenous ecotropic murine leukemia virus AKR623 that are recognized by anti-AKR/Gross MuLV CTL.
White HD; Roeder DA; Lam T; Green WR
Viral Immunol; 1994; 7(2):51-9. PubMed ID: 7848510
[TBL] [Abstract][Full Text] [Related]
11. The immune response to Moloney murine leukemia virus-induced tumors: induction of cytolytic T lymphocytes specific for both viral and tumor-associated antigens.
Flyer DC; Burakoff SJ; Faller DV
J Immunol; 1986 Dec; 137(12):3968-72. PubMed ID: 3491152
[TBL] [Abstract][Full Text] [Related]
12. Impaired generation of anti-AKR/Gross murine leukemia virus cytotoxic T lymphocytes in mice experimentally infected with MuLV.
Coppola MA; Green WR; Rich RF
Viral Immunol; 1996; 9(2):107-19. PubMed ID: 8822627
[TBL] [Abstract][Full Text] [Related]
13. FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens.
Klarnet JP; Kern DE; Okuno K; Holt C; Lilly F; Greenberg PD
J Exp Med; 1989 Feb; 169(2):457-67. PubMed ID: 2562982
[TBL] [Abstract][Full Text] [Related]
14. Mutations in H-2Kb influence the specificity of alloreactive effector cells included in the repertoire of H-2Db-restricted cytotoxic T lymphocytes against Moloney leukemia virus.
Stukart MJ; Boes J; Melief CJ
Immunogenetics; 1983; 17(4):427-36. PubMed ID: 6601058
[TBL] [Abstract][Full Text] [Related]
15. Hierarchal utilization of different T-cell receptor Vbeta gene segments in the CD8(+)-T-cell response to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
Brawand P; Cerottini JC; MacDonald HR
J Virol; 1999 Nov; 73(11):9161-9. PubMed ID: 10516023
[TBL] [Abstract][Full Text] [Related]
16. A single amino acid variation within an immunodominant AKR/Gross MuLV cytotoxic T-lymphocyte epitope leads to a loss in immunogenicity.
Kim V; Green WR
Viral Immunol; 1998; 11(4):197-213. PubMed ID: 10189187
[TBL] [Abstract][Full Text] [Related]
17. A shift in the requirement for CD4+ T cells in the generation of AKR/Gross MuLV-specific CTL in AKR.H-2b:Fv-1b mice occurs prior to the onset of age-dependent CTL nonresponsiveness.
Smith PM; Rich RF; Green WR
Cell Immunol; 1997 Feb; 175(2):189-98. PubMed ID: 9023425
[TBL] [Abstract][Full Text] [Related]
18. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T lymphocyte nonresponsiveness to the male antigen H-Y in the H-2Db mutants bm13 and bm14. Complementation of the response in F1 crosses with the I-Ab mutant bm12 nonresponder and failure of B6 or Db mutant mice tolerant of each other to respond to allogeneic male cells.
De Waal LP; Melvold RW; Melief CJ
J Exp Med; 1983 Nov; 158(5):1537-46. PubMed ID: 6415206
[TBL] [Abstract][Full Text] [Related]
20. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
